Life Sciences

Get timely insights into the fast moving Life Sciences industry with news highlighting breakthrough research, biotech advances, regulatory developments, and market shaping trends. This category delivers impactful updates that inform professionals as innovation, technology, and scientific discovery continue to reshape global health and the future of medical progress.

EU Approves PYRUKYND (mitapivat) for Adult Thalassemia Care

The European Commission has approved PYRUKYND (mitapivat) for adults living with alpha- or beta-thalassemia across European Union member states. The decision marks a significant milestone because PYRUKYND becomes the only approved medicine in Europe for...

Publication Date: May 26, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Nuclear Medicine: Transforming Modern Diagnostic Imaging

Modern healthcare continues to evolve rapidly, and nuclear medicine now stands at the forefront of diagnostic innovation. It provides a unique blend of functional imaging and clinical precision, enabling clinicians to detect diseases earlier and...

Publication Date: May 26, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Approves Datopotamab Deruxtecan-Dlnk for TNBC

The U.S. Food and Drug Administration approved datopotamab deruxtecan-dlnk for adults with unresectable or metastatic triple-negative breast cancer (TNBC). The approval targets patients who are not candidates for PD-1 or PD-L1 inhibitor therapy. Consequently, the...

Publication Date: May 25, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Regeneron–Parabilis Medicines to Advance Antibody-Helicon Conjugates

Regeneron Pharmaceuticals announced a strategic collaboration with Parabilis Medicines to develop cutting-edge therapies. The agreement centers on antibody-Helicon conjugates, a novel approach designed across multiple therapeutic areas to target intracellular proteins that traditional therapies cannot...

Publication Date: May 19, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Approves fam-trastuzumab deruxtecan-nxki in Breast Cancer for HER2 Therapy

The U.S. Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki for two new indications in HER2-positive early-stage breast cancer treatment. Additionally, the decision significantly broadens the role of fam-trastuzumab deruxtecan-nxki in curative-intent care settings across earlier...

Publication Date: May 18, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Lilly–UNICEF Expand Non-Communicable Disease Care

A major global collaboration has launched to improve non-communicable disease prevention and treatment for children. The six-year initiative aims to reach more than 30 million children, adolescents, and caregivers across 21 low- and middle-income countries.The...

Publication Date: May 15, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Clears Sonrotoclax for Mantle Cell Lymphoma

The U.S. Food and Drug Administration has granted accelerated approval to sonrotoclax for adults with relapsed or refractory mantle cell lymphoma. The approval marks an important milestone for patients who previously exhausted several treatment options....

Publication Date: May 14, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

BMS–Hengrui Announced Collaboration to Accelerate Innovative Medicines

Bristol Myers Squibb (BMS) and Hengrui Pharma announced a global partnership to speed up the discovery and development of new medicines in oncology, hematology, and immunology. This partnership has two research-focused organizations that have complementary...

Publication Date: May 13, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Clears Zenocutuzumab-zbco for Rare Bile Duct Cancer

The U.S. Food and Drug Administration approved zenocutuzumab-zbco for advanced cholangiocarcinoma, creating a new treatment option for patients with rare cancers. The approval targets adults with advanced, unresectable, or metastatic cholangiocarcinoma carrying a neuregulin 1...

Publication Date: May 11, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

AHA, West Health Advanced Healthcare Technology Nationwide

The American Hospital Association and West Health have launched a national accelerator to expand healthcare technology adoption across hospitals and health systems nationwide. The initiative aims to scale innovative solutions while improving patient care delivery,...

Publication Date: April 30, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

News 1 to 10 | Total Count : 90

1

© The News and Media Division of The Insight Partners 2026 | All Rights Reserved | Privacy Policy